Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
53.9M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
53.6M
-
Shares change
-
+4.9M
-
Total reported value, excl. options
-
$500M
-
Value change
-
+$34.7M
-
Put/Call ratio
-
0.22
-
Number of buys
-
61
-
Number of sells
-
-47
-
Price
-
$9.30
Significant Holders of Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) as of Q1 2025
135 filings reported holding TYRA - Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.6M shares
of 53.9M outstanding shares and own 99.41% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.6M shares), Canaan Partners XI LLC (4.14M shares), Alta Partners Management Company, L.P. (4.08M shares), Nextech Invest, Ltd. (4.06M shares), BVF INC/IL (3.94M shares), TCG Crossover Management, LLC (2.9M shares), Vestal Point Capital, LP (2.88M shares), JANUS HENDERSON GROUP PLC (2.69M shares), Kynam Capital Management, LP (2.41M shares), and ORBIMED ADVISORS LLC (1.75M shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.